. Show Affiliations »
Abstract
Mesh: See more » Biosimilar PharmaceuticalsDeveloping CountriesHealth Services AccessibilityHumans
Substances: See more » Biosimilar Pharmaceuticals
Year: 2017 PMID: 28513438 DOI: 10.1016/S0140-6736(17)31272-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321